Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Cancer. 2011 Oct 1;117(19):4424–4438. doi: 10.1002/cncr.26073

Figure 5. DAC reactivates ARHI and PEG3 expression in ovarian cancer cells.

Figure 5

(A) Hey and (B) SKOv3 cells were treated for 5 days with indicated concentrations of DAC, SAHA, or a combination. Cells were analyzed for cell proliferation by SRB staining (left column), and for ARHI (middle column) and PEG3 (right column) expression by real-time RT-PCR. The quantitative analyses were repeated at least two times and one representative experiment is shown.